Painchek Ltd has released a press release.
ePAT Clinical Study Published in Alzheimers Disease Journal
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from PainChek
- nViso agrees perpetual global license, takes strategic stake
- ePAT Pain Assessment App Secures Regulatory Clearance
- New Study Validates Face Recognition App in Pain Detection
- Launch of IBM Case Study
- Second Quarter Report FY 2016/17
Later from PainChek
- Core strategic agreement with Dementia Support Australia
- Placement to raise $3.75 million
- ePAT and PainChek continue to achieve commercial milestones
- 2nd peer-review confirms excellent performance of PainChek
- New Peer reviewed published study
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek